RT Journal Article
SR Electronic
A1 Cunningham, Muriel
T1 RAINBOW Study Shows Significant Benefits in OS and PFS in Western Patients with Gastric Cancer
JF MD Conference Express
YR 2014
FD SAGE Publications
VO 14
IS 22
SP 13
OP 14
DO 10.1177/155989771422009
UL http://mdc.sagepub.com/content/14/22/13.abstract
AB The Study of Paclitaxel With or Without Ramucirumab (IMC-1211B) in Metastatic Gastric Adenocarcinoma [RAINBOW; NCT01170663] is an international double-blind Phase 3 study of patients with metastatic gastric or gastroesophageal junction adenocarcinoma. This article presents the results from the planned region 1 subgroup analysis [Wilke H et al. Ann Oncol. 2014 (abstr O-0006)] consisting of Europe, Israel, the United States, and Australia.